Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

943 recalls · Class II, newest first

Class II · Moderate risk

Prednisone Tablets

Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg

Terminated Labeling / mix-up Lannett Company, Inc. NDC 0527-2931-37 D-1508-2020
Class II · Moderate risk

Just Hand Sanitizer

Labeling Not Elsewhere Classified: Product labeled to contain methanol

Terminated Labeling / mix-up Open Book Extracts NDC 78065-2020-2 D-1564-2020
Class II · Moderate risk

Lidocaine Patch 5%

Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.

Terminated Labeling / mix-up Teva Pharmaceuticals USA NDC 0591-3525-30 D-1492-2020
Class II · Moderate risk

Aripiprazole Tablets

Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.

Terminated Labeling / mix-up Alembic Pharmaceuticals Limited NDC 62332-097-30 D-1341-2020
Class II · Moderate risk

Gaviscon Liquid Antacid Extra Strength

Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings NDC 0135-0095-41 D-1325-2020
Class II · Moderate risk

Lisinopril Tablets

Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

Terminated Labeling / mix-up Lupin Pharmaceuticals Inc. NDC 68180-513-03 D-1290-2020
Class II · Moderate risk

Lisinopril Tablets USP

Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.

Terminated Labeling / mix-up Lupin Pharmaceuticals Inc. NDC 68180-0981-03 D-1250-2020
Class II · Moderate risk

Advil Liqui-Gel Mini 160+20+20 CT

Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings NDC 0573-1715-59 D-1069-2020
Class II · Moderate risk

Theraflu Cough Relief

Labeling: Label Lacks Warning: Product recalled due to absence of a warning statement on the product label, Ask a doctor before use if you have a sodium-restricted diet.

Terminated Labeling / mix-up GSK Consumer Health, Inc D-0996-2020
Class II · Moderate risk

Testosterone Topical Cream 4%

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0820-2020
Class II · Moderate risk

Tadalafil 6 mg Capsule

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0819-2020

Recalls by year